
Kiniksa Pharmaceuticals, Ltd. KNSA
€ 45.51
0.28%
Quartalsbericht 2026-Q1
hinzugefügt 28.04.2026
Kiniksa Pharmaceuticals, Ltd. P/B 2011-2026 | KNSA
P/B Jährlich Kiniksa Pharmaceuticals, Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.77 | 3.25 | 3.26 | 2.19 | 4.16 | 3.9 | 3.55 | 3.24 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.77 | 2.19 | 3.67 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 9.13 | -0.76 % | $ 591 M | ||
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.485 | $ 0.91 | 2.42 % | $ 6.69 M | ||
|
Edesa Biotech
EDSA
|
3.07 | $ 15.52 | -2.39 % | $ 49.6 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.47 | 1.19 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Fortress Biotech
FBIO
|
1.25 | $ 2.24 | 0.9 % | $ 62.5 M | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 2.26 | 0.22 % | $ 144 M | ||
|
Galapagos NV
GLPG
|
1.67 | $ 28.07 | 0.75 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
1.15 | $ 8.2 | 3.6 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
1.85 | $ 31.01 | -0.13 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
2.15 | $ 8.44 | - | $ 76.2 M | ||
|
InflaRx N.V.
IFRX
|
1.41 | $ 1.95 | -1.77 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
67.2 | $ 0.83 | 3.44 % | $ 6.55 M | ||
|
Incyte Corporation
INCY
|
3.77 | $ 98.87 | -0.23 % | $ 19.3 B | ||
|
InMed Pharmaceuticals
INM
|
0.142 | $ 0.71 | 1.28 % | $ 1.74 M | ||
|
INmune Bio
INMB
|
1.2 | $ 1.35 | 1.5 % | $ 33.4 M | ||
|
Innoviva
INVA
|
0.992 | $ 23.13 | 0.35 % | $ 1.56 B | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 104.54 | 2.92 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Jaguar Health
JAGX
|
-0.0512 | $ 7.55 | -4.13 % | $ 17.6 M | ||
|
KalVista Pharmaceuticals
KALV
|
-308 | $ 26.67 | -0.02 % | $ 1.44 B | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Innate Pharma S.A.
IPHA
|
1.36 | $ 1.43 | -4.03 % | $ 235 M | ||
|
Kamada Ltd.
KMDA
|
0.85 | $ 8.15 | 0.49 % | $ 260 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
Kazia Therapeutics Limited
KZIA
|
7.11 | $ 13.24 | 6.56 % | $ 1.75 B | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.67 | $ 223.98 | -0.39 % | $ 4.1 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 3.22 | 7.69 % | $ 5.3 M | ||
|
Liquidia Corporation
LQDA
|
65.9 | $ 38.39 | 0.62 % | $ 3.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.08 | 0.74 % | $ 436 M |